Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2019 09:05 ET | Source: Assertio Therapeutics, Inc.

Assertio Therapeutics to Report Third-Quarter 2019 Financial Results After the Close of Markets on Wednesday, November 6, 2019

LAKE FOREST, Ill., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it will release third-quarter 2019 financial results on Wednesday, November 6,...
October 21, 2019 09:05 ET | Source: Assertio Therapeutics, Inc.

Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin

LAKE FOREST, Ill., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), today announced that its development partner West Therapeutic Development, LLC (West) has received a...
September 30, 2019 12:35 ET | Source: Assertio Therapeutics, Inc.

Assertio Therapeutics Announces Appointment of Dr. David Wheadon to its Board of Directors

LAKE FOREST, Ill., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Dr. David Wheadon has been appointed to the Company’s Board of Directors. Dr....
September 26, 2019 08:00 ET | Source: Assertio Therapeutics, Inc.

Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference

LAKE FOREST, Ill., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Annual Cantor Fitzgerald...
August 20, 2019 08:00 ET | Source: Assertio Therapeutics, Inc.

Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference

LAKE FOREST, Illinois, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 17th Annual Morgan...
August 09, 2019 09:28 ET | Source: Assertio Therapeutics, Inc.

Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021

LAKE FOREST, Ill., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) (“Assertio”) today announced it has entered into separate, privately negotiated exchange agreements...
August 07, 2019 16:02 ET | Source: Assertio Therapeutics, Inc.

Assertio Therapeutics Announces Strong Second-Quarter 2019 Results

-- Reports Total Company GAAP Net Sales of $57.2 million, Total Company Non-GAAP Net Sales of $59.3 million, including Commercialization Agreement Revenues of $31.0 million -- -- Drives Continued...
July 17, 2019 16:05 ET | Source: Assertio Therapeutics, Inc.

Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 2019

LAKE FOREST, Ill., July 17, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release second quarter 2019 financial results on Wednesday, August 7,...
May 08, 2019 16:02 ET | Source: Assertio Therapeutics, Inc.

Assertio Therapeutics Announces First-Quarter 2019 Financial Results

-- Reports Neurology Franchise Net Sales of $26.3 million -- -- Commercialization Agreement Revenues of $30.9 million -- -- Raises 2019 Earnings Guidance Range and Confirms Neurology Franchise Net...
April 24, 2019 16:46 ET | Source: Assertio Therapeutics, Inc.

Assertio Therapeutics to Report First Quarter 2019 Financial Results After The Close of Markets on Wednesday, May 8, 2019

LAKE FOREST, Ill., April 24, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release first quarter 2019 financial results on Wednesday, May 8, 2019,...